Pfizer Receives EC Approval to Expand Use of XALKORI to First-Line Treatment of Adults with ALK-Positive Advanced NSCLC
November 25, 2015 at 04:14 AM EST
Pfizer Inc. (NYSE: PFE) today announced that the European Commission has approved a label update to expand use of ...